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Abstract 
Renal cell carcinoma (RCC) is the fifth most common malignancy in kidney transplant recipients, 
with increased risk arising due to immunosuppression. De novo RCC occurrence in kidney 
allografts is much less common when compared with the native kidneys. Multifocal RCC in 
allograft kidneys is rarely described. In this report, we discuss two cases of de novo multifocal 
renal neoplasms in allograft kidneys. Case 1 had three distinct neoplastic lesions of >5 mm, and 
case 2 had four. Using the World Health Organization 2016 classification of adult renal tumours, 
case 1 had one clear-cell (cc) RCC (grade 3) and two papillary adenomas; all confined to the 
kidney. Case 2 had a nodular lesion classified as ccRCC (grade 4) with focal rhabdoid 
differentiation and some infiltration of renal sinus fat; a cc tubulopapillary RCC; a multilocular 
cystic renal neoplasm of low malignant potential; and a mucinous tubular and spindle cell 
carcinoma; the last three all confined to the kidney. This is the first report of mucinous tubular 
and spindle cell carcinoma in a kidney allograft. When considering multifocal RCC with 
discordant histology, it is likely that these represent independent tumourigenic events. 
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Introduction 
Transplant recipients are at a 
substantially increased risk of developing 
malignancy due to immunosuppression 
regimens necessary to maintain graft 
viability. This may be due to decreased 
tumour antigen surveillance and/or 
increased risk of oncogenic infections 
(e.g. Epstein-Barr virus) (1). Renal cell 
carcinoma (RCC) is the fifth most 
common malignancy in kidney transplant 
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recipients, and there is an estimated 15-
fold increased risk when compared with 
the general population (2). The majority 
of these cancers arise in native kidneys, 
where end-stage or acquired cystic 
parenchymal changes often compound 
cancer risk, in conjunction with 
immunosuppression. Malignancies 
arising in allografts are substantially less 
common. 
Reports of multifocal RCC in allograft 
kidneys are sparse although multifocal 
RCC has been reported in 5–25% of all 
sporadic RCC cases (3). Synchronous 
multifocal RCC is a common finding in 
association with many hereditary 
conditions (e.g. von Hippel-Lindau [VHL] 
disease and Birt-Hogg-Dubé syndrome); 
however, outside these conditions, there 
is a conflicting evidence as to exact 
pathogenic mechanisms, namely, whether 
tumours arise independently or as a 
result of intrarenal metastasis. When 
considering multifocal RCC with 
discordant histology, it is likely that 
these represent independent tumorigenic 
events (4). Although concomitant 
tumours have been reported following 
kidney transplantation, they are generally 
spatiotemporally demarcated (5). This 
report details two cases of multifocal de 
novo RCC arising in kidney allografts, 
with particular focus on the pathological 
findings. In both cases, there were 
multiple co-existing renal neoplasms with 
variable histological features within the 
graft kidney. 
Patients and methods 
Ethics approval 
Relevant approvals were granted by 
institutional ethics review boards. 
Written informed consent was obtained 
prior to patient inclusion. 
Patients 
Retrospective analysis was undertaken 
reviewing the records of 183 patients who 
underwent tumour nephrectomy at the 
Princess Alexandra Hospital (Queensland, 
Australia) between June 2013 and 
December 2015. We identified nine of 
these patients as being kidney transplant 
recipients. Of these nine, two had lesions 
within their allograft kidney. Both 
patients received conventional transplant 
nephrectomy. 
Case 1 
A 55-year-old man underwent graft 
nephrectomy after a solid mass lesion 
was detected in his transplanted kidney 
on ultrasound and confirmed by 
computed tomographic (CT) scan (Figure 
1A-C). The kidney transplant was 
performed in 1997 following end-stage 
kidney disease due to focal segmental 
glomerulosclerosis (18-year functioning 
graft; estimated glomerular filtration rate 
[eGFR] prior to surgery was 45 ml/min 
per 1.73 m2). Immunosuppressive 
therapeutic regimen prior to surgery 
included prednisolone (5 mg/day), 
mycophenolate mofetil (2000 mg/day) 
and tacrolimus (0.5 mg/day). In the non-
neoplastic kidney sections, there were 
glomerular hypertrophy and focal 
segmental glomerulosclerosis, with no 
transplant glomerulopathy. Mild 
transplant arteriopathy was present, and 
there was minimal tubular 
atrophy/interstitial fibrosis (<10% 
cortex). There was no evidence of 
rejection. Multiple simple cortical cysts 
(Figure 2A) and papillary adenomas (<5 
mm) were present. 
The following lesions were also found in 
the kidney: a nodular lesion present in 
the upper pole (35 mm at largest 
dimension) classified as clear-cell (cc) 
RCC (WHO/ISUP grade 3); and two 
additional nodules (8 and 9 mm at largest 
dimension) were identified in the lower 
pole, both classified as papillary 
adenomas. Both of these lesions were 
initially classified as type 1 papillary RCC 
(grade 2); however, these lesions were 
reclassified by a uropathologist as 
papillary adenomas, based on the World 
Health Organization 2016 classification of 
adult renal tumours (lesions are <15 mm 
at largest dimension) (6). All tumours 
were confined to the kidney (Figure 3). 
Case 2 
A 44-year-old man underwent graft 
nephrectomy after a solid mass lesion 
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Figure 1. A. Computer tomographic scan (CT) case 1: coronal section showing transplant kidney in 
left iliac fossa; distinct mass present in upper pole and enhanced with contrast, designated by arrow. 
B. CT case 1: transverse section showing distinct mass in transplant kidney enhanced with contrast, 
predominantly posteriorly located. C. Ultrasound case 1: showing distinct mass within kidney. D. CT 
case 2, coronal section showing transplant kidney in right iliac fossa; indiscriminate mass located in 
lower pole without contrast enhancement. E. CT case 2, transverse section showing indiscriminate 
mass in posterior portion of kidney. F. Ultrasound case 2, showing distinct mass in posterior portion 
of kidney cortex. 
was detected in his transplanted kidney on 
ultrasound, and confirmed by a CT scan 
(Figure 1D-F). The transplant was received 
in 1996 (19-year functioning graft; eGFR 
prior to surgery was 26 ml/min per 1.73 m2). 
Histology of the non-neoplastic kidney 
showed mild parenchymal scarring with 
some glomerulitis and transplant 
glomerulopathy present. Moderate transplant 
arteriopathy and hyaline arteriosclerosis 
were also present. Indications of active 
chronic antibody-mediated rejection were 
present in the microvessels (glomerular and 
peritubular capillaries) and arteries, as 
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Figure 2. A. Bivalved allograft kidney, case 1: Primary lesion is clear-cell renal cell carcinoma (ccRCC) 
visible in upper pole (a.). Papillary adenomas not easily visualised. Cortical cyst visible (b.). B. 
Bivalved allograft kidney, case 2 : primary lesion (ccRCC) visible in lower pole (c.); note invasion into 
renal sinus fat. 
evidenced by C4d immunoperoxidase stain 
positivity. Multiple cortical cysts were 
present. 
A nodular lesion present in the lower pole 
(50 mm at largest dimension) was classified 
as ccRCC (grade 4), with focal rhabdoid 
differentiation (Figure 4). This tumour 
showed some infiltration of renal sinus fat 
(Figure 2B). A second lesion in the lower 
pole (37 mm at largest dimension) was 
classified as a cc tubulopapillary RCC (low 
Figure 3. Case 1: A and B. Clear-cell renal cell carcinoma, grade 3; high- and low-power fields of the 
two papillary adenomas are shown in C and D and E and F. 
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Figure 4. Case 2: A and B. Low-power fields showing clear cell renal cell carcinoma. C. High-power 
field showing rhabdoid differentiation. D. High-power field showing features consistent with a grade 
of 4. 
grade; Figure 5A-C). A third lesion in the 
lower pole (7 mm at largest dimension) was 
classified as multilocular cystic renal 
neoplasm of low malignant potential 
(Figure 5D-F). A 7-mm lesion in the upper 
pole was classified as mucinous tubular 
and spindle cell carcinoma (Figure 6). 
These tumours were limited to the kidney. 
Discussion 
Here, we report two cases of multifocal 
synchronous neoplasms in allograft 
kidneys, with variable histological 
concordance. We found three similar case 
studies in the literature (7–9), and a case 
series identified a further 12 cases of 
multifocal RCC in allograft kidneys (10). 
Malignancies arising in allograft kidneys 
have three primary mechanisms of 
pathogenesis: (i) de novo malignancy, (ii) 
recurrence of previous malignancy (i.e. 
RCC) or (iii) transmission of malignancy 
from donor (11). In the absence of 
previous RCC history and considering the 
long life of both grafts, it can be 
presumed that both cases exhibit de novo 
malignancy (10). Although multifocal 
neoplasms in allograft kidneys are 
sparsely reported, a recent study of 2,569 
nephrectomy patients revealed a 3% 
prevalence of ipsilateral multifocal 
synchronous RCC in the general 
population, with only 58.8% histological 
concordance (12). This indicates that 
with multifocal lesions, it is not 
uncommon for multiple histological 
subtypes to be found. 
The predominant mass in both cases was 
ccRCC (summarised in Table 1). 
Although there is dispute as to whether 
multifocal ccRCC is the result of related 
or independent events (13, 14), there is 
no indication that they give rise to other 
subtypes. Considering case 1, it has been 
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Figure 5. Case 2: A-C. Clear-cell tubulopapillary renal cell carcinoma. D-F. Multilocular cystic renal 
neoplasm of low malignant potential. 
reported that multifocal papillary RCC 
generally arise independently (15). This 
tends to indicate that the multiple 
papillary adenomas probably arose from 
independent tumorigenic events, 
especially considering that multifocal 
papillary adenomas are not uncommon 
and often are associated with multifocal 
papillary RCC (15). 
Considering case 2, cc tubulopapillary 
RCC by definition do not exhibit 3p 
deletion, chromosome 7 or 17 polysomy, 
or VHL mutations, as is generally found 
in ccRCC (16). Based on this, polyclonal 
origin of these lesions is extremely likely. 
Of the three previous case studies of 
multifocal RCC in allografts, two showed 
discordant histological subtypes. The first 
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Figure 6. Case 2: A. Low-power and (B) high-power fields showing mucinous tubular and spindle cell 
carcinoma. 
case was of a high-grade ccRCC and 
papillary RCC (7), and the second showed 29 
separate lesions with multiple classifications, 
predominantly papillary RCC or adenoma (9). 
Evaluation of the cases presented in this 
report, and previously reported, provides 
some evidence that multiple tumorigenic 
mutations may lead to multifocal 
synchronous RCC occurrence in kidney 
allografts. Although immunosuppression 
presents as a common factor, it is not 
possible to determine whether it 
predisposes to multiple mutations, as 
causes are almost always multifactorial. 
Additional research to determine the 
relationship between immunosuppression 
and tumorigenic events is required. 
There are important connotations regarding 
methods to diagnose allograft tumours, and 
further support for ongoing tumour 
screening in kidney transplant recipients 
with long graft life. First, as identified by 
Simhan et al. (12), if a single region of an 
intrarenal mass is biopsied and found to be 
of low malignant potential, there is no 
guarantee that there is not a concomitant 
high-grade tumour also present. The 
importance of thorough and appropriate 
radiological examination is also 
demonstrated because if multifocal lesions 
are present, there is a possibility that 
innocuous masses may be overlooked with 
subsequent progression (especially relevant 
in the context of nephron-sparing surgery). 
Difficulty in this regard can be compounded 
as radiographic contrast is often 
contraindicated in patients with diminishing 
graft kidney function (as the case in Figure 
1D-E). Although there is not enough 
evidence to justify adjustments of diagnostic 
protocols at present, we do highlight the 
importance of thorough and accurate 
radiographic/histologic evaluation of patients 
with suspected kidney allograft neoplasia.
 
       Table 1. Histological Diagnosis of Lesions 
Histology Size (mm) 
Case 1 
 Clear cell RCC 35 
 Papillary adenoma 8 
 Papillary adenoma 9 
Case 2 
 Clear-cell RCC 50 
 Clear-cell tubulopapillary RCC 37 
 Multilocular cystic renal neoplasm 7 
 Mucinous tubular and spindle cell carcinoma 7 
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Conclusion 
Overall, we report two cases of multifocal 
allograft neoplasms with low histological 
concordance. Although our findings are 
limited by the lack of genetic analysis of 
tumour tissue, based on the available 
literature, it appears that they are the 
result of independent tumorigenic 
mutations as opposed to intrarenal 
metastatic spread. Although there is not 
enough evidence to implicate 
immunosuppression as the sole causative 
factor, further investigation into this link is 
warranted. Our findings highlight the 
importance of effective and thorough 
radiologic and histologic analyses of 
tumours present in kidney allografts. 
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